USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Recent Advancements in Drug Delivery Novel Formulations and Technologies Offer Improved Treatment Options
Vital Signs - Recent Advancements in Drug Delivery Novel Formulations and Technologies Offer Improved Treatment Options
RELEASE DATE
13-Aug-2012
13-Aug-2012
REGION
North America
North America
Research Code: 9561-00-E5-00-00
SKU: HC00655-NA-MR_04128
$1,500.00
In stock
SKU
HC00655-NA-MR_04128
Description
This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery.
Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement and regulatory news from the FDA is also provided for week of July 30, 2012.
Table of Contents
This week's issue
Popular Topics
This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery. Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement and regulatory news from the FDA is also provided for week of July 30, 2012.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-E5-00-00 |
| Is Prebook | No |